Méhnyakrák: vizsgálatok itt: Belarusz

1 trial · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

• 2/3. fázisTaking people
  PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

  Where

  Minsk

  Életkor

  18 év to 75 év

  People

  120

  Run by

  N.N. Alexandrov National Cancer Centre

  See details and how to joinNCT07472153